Premium
Proteomic characterization of differentially expressed proteins in breast cancer: Expression of hnRNP H1, RKIP and GRP78 is strongly associated with HER‐2/ neu status
Author(s) -
Zhang Daohai,
Tai Lee Kian,
Wong Lee Lee,
Putti Thomas C.,
Sethi Sunil K.,
Teh Ming,
Koay Evelyn S. C.
Publication year - 2008
Publication title -
proteomics – clinical applications
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.948
H-Index - 54
eISSN - 1862-8354
pISSN - 1862-8346
DOI - 10.1002/prca.200780099
Subject(s) - biology , lapatinib , immunohistochemistry , breast cancer , cancer research , neuregulin , ribonucleoprotein , erbb3 , heterogeneous nuclear ribonucleoprotein , microbiology and biotechnology , metastasis , kinase , cancer , signal transduction , receptor tyrosine kinase , gene , trastuzumab , immunology , rna , genetics
The human epidermal growth factor receptor type 2 (HER‐2/ neu ) oncoprotein is overexpressed in about 30% of breast cancers and associates with metastatic phenotypes of breast tumours. Dissecting the HER‐2/ neu ‐modulated molecules in cancer will be helpful in elucidating the underlying molecular mechanisms of HER‐2/ neu ‐driven tumourigenesis. We investigated the differential proteome profiles between microdissected HER‐2/ neu ‐positive and ‐negative tumours and unambiguously identified 21 proteins with diverse biological functions by peptide sequencing and NCBInr database interrogation. Six proteins were up‐regulated whereas 15 were down‐regulated in the HER‐2/ neu ‐positive tumours. Differential expressions of heterogeneous nuclear ribonucleoprotein H1 (hnRNP H1), 78 kDa glucose‐regulated protein (GRP78/Bip) and Raf‐1 kinase inhibitor protein (RKIP), which have not been previously reported as being linked to HER‐2/ neu signalling, were further verified. Immunohistochemical staining on tissue microarray sections demonstrated a positive correlation of hnRNP H1 ( p = 0.008) and negative correlations of GRP78 and RKIP ( p = 0.018 and 0.013, respectively) with HER‐2/ neu . Heregulin α1 enhanced hnRNP H1, but reduced GRP78 and RKIP expression in BT474 cells in a dose‐dependent manner, providing evidence of crosstalk between HER‐2/ neu signalling and these modulators. Our studies have identified novel modulators that are likely to be intricately involved in HER‐2/ neu ‐driven tumour proliferation, invasion and metastasis.